The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma

被引：0
|
作者：
Peiyu Yang
Fan Zhou
Yujun Dong
Guangxun Gao
Hua Xue
Xinyue Liang
Shanshan Yu
Weiling Xu
Yanping Ma
Xiaoqi Qin
Mengyao Li
Yun Dai
Fengyan Jin
机构：
[1] the First Hospital of Jilin University,Department of Hematology
[2] the First Hospital of Jilin University,Laboratory of Cancer Precision Medicine
[3] Shanghai Jing’an District Zhabei Central Hospital,Department of Hematology and Oncology
[4] Peking University First Hospital,Department of Hematology
[5] Xijing Hospital,Department of Hematology
[6] Air Force Medical University,Department of Hematology
[7] the Affiliated Hospital of Hebei University,Department of Radiology
[8] the First Hospital of Jilin University,Department Hematology
[9] the Second Hospital of Shanxi Medical University,undefined
来源：
Blood Cancer Journal | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients
    Suriu, C.
    Akria, L.
    Azoulay, D.
    Shaoul, E.
    Barhoum, M.
    Braester, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (03) : e56 - e59
  • [22] Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent era
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Wang, Huijuan
    Li, Yanchen
    Leng, Yun
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    HEMATOLOGY, 2023, 28 (01)
  • [23] The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
    Yao, Weiqin
    Yang, Haifei
    You, Hongying
    Shang, Jingjing
    Zhai, Yingying
    Yan, Zhi
    Yan, Shuang
    Shi, Xiaolan
    Yao, Ying
    Wang, Jing
    Wang, Panfeng
    Xu, Yun
    Jin, Song
    Yan, Lingzhi
    Wu, Depei
    Fu, Chengcheng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Value Of Serum Free Light Chains Ratio As New Biomarker Of High Prognostic Value In Patients With Newly Diagnosed Multiple Myeloma
    Silva, Jose Luis Garcia de Veas
    Bermudo, Carmen
    Harding, Stephen
    Millan, Rafael Duro
    BLOOD, 2013, 122 (21)
  • [25] Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study
    Lee, Gin-Yi
    Lee, Yu-Ting
    Yeh, Chiu-Mei
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 726 - 733
  • [26] Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
    Larsen, Rikke Faebo
    Jarden, Mary
    Minet, Lisbeth Rosenbek
    Frolund, Ulf Christian
    Moeller, Soeren
    Abildgaard, Niels
    BMC CANCER, 2020, 20 (01)
  • [27] Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
    Rikke Faebo Larsen
    Mary Jarden
    Lisbeth Rosenbek Minet
    Ulf Christian Frølund
    Sören Möller
    Niels Abildgaard
    BMC Cancer, 20
  • [28] Thalidomide and Dexamethasone Maintenance after Autologous Stem Cell Transplantation in Newly Diagnosed Korean Multiple Myeloma Patients: A Prospective Multi-Center Study in Asia
    Kim, Sang-A
    Yoon, Sung-Soo
    Koh, Youngil
    Shin, Dong-Yeop
    Kim, Jin Seok
    Kim, Kihyun
    Min, Chang-Ki
    Eom, Hyeon-Seok
    Lee, Je-Jung
    Lee, Jeong-Ok
    Bang, Soo-Mee
    BLOOD, 2017, 130
  • [29] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [30] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
12345